Serial cardiac biomarkers, pulmonary artery pressures and traditional parameters of fluid status in relation to prognosis in patients with chronic heart failure: Design and rationale of the BioMEMS study
Allach, Youssra; Barry-Loncq de Jong, Mylene; Clephas, Pascal R D; van Gent, Marco W F; Brunner-La Rocca, Hans-Peter; Szymanski, Mariusz K; van Halm, Vokko P; Handoko, M Louis; Kok, Wouter E M; Asselbergs, Folkert W; van Kimmenade, Roland R J; Manintveld, Olivier C; van Mieghem, Nicolas M D A; Beeres, Saskia L M A; Rienstra, Michiel; Post, Marco C; van Heerebeek, Loek; Borleffs, C Jan Willem; Tukkie, Raymond; Mosterd, Arend; Linssen, Gerard C M; Spee, Ruud F; Emans, Mireille E; Smilde, Tom D J; van Ramshorst, Jan; Kirchhof, Charles J H J; Feenema-Aardema, Margriet W; da Fonseca, Carlos A; van den Heuvel, Mieke; Hazeleger, Ronald; van Eck, J W Martijn; Boersma, Eric; Kardys, Isabella; de Boer, Rudolf A; Brugts, Jasper J
(2024) European Journal of Heart Failure, volume 26, issue 8, pp. 1736 - 1744
(Article)
Abstract
AIMS: Heart failure (HF), a global pandemic affecting millions of individuals, calls for adequate predictive guidance for improved therapy. Congestion, a key factor in HF-related hospitalizations, further underscores the need for timely interventions. Proactive monitoring of intracardiac pressures, guided by pulmonary artery (PA) pressure, offers opportunities for efficient early-stage intervention,
... read more
since haemodynamic congestion precedes clinical symptoms. METHODS: The BioMEMS study, a substudy of the MONITOR-HF trial, proposes a multifaceted approach integrating blood biobank data with traditional and novel HF parameters. Two additional blood samples from 340 active participants in the MONITOR-HF trial were collected at baseline, 3-, 6-, and 12-month visits and stored for the BioMEMS biobank. The main aims are to identify the relationship between temporal biomarker patterns and PA pressures derived from the CardioMEMS-HF system, and to identify the biomarker profile(s) associated with the risk of HF events and cardiovascular death. CONCLUSION: Since the prognostic value of single baseline measurements of biomarkers like N-terminal pro-B-type natriuretic peptide is limited, with the BioMEMS study we advocate a dynamic, serial approach to better capture HF progression. We will substantiate this by relating repeated biomarker measurements to PA pressures. This design rationale presents a comprehensive review on cardiac biomarkers in HF, and aims to contribute valuable insights into personalized HF therapy and patient risk assessment, advancing our ability to address the evolving nature of HF effectively.
show less
Download/Full Text
Keywords: Biomarkers, Haemodynamic monitoring, Heart failure, Intracardiac pressures, Repeated measurements, Risk stratification, Cardiology and Cardiovascular Medicine, Journal Article
ISSN: 1388-9842
Publisher: Oxford University Press
Note: Publisher Copyright: © 2024 The Author(s). European Journal of Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.
(Peer reviewed)